|
|
Type of Company:
Type:
|
Company
|
Ownership: |
Privately Held (Funded) |
Company Size: |
50-99 Employees In BC (50-99 Total)
50-99 In BC (50-99 Total)
|
Year Founded: |
2013 |
Sector: |
Biotech/Life Sciences
Biotech/Life Sciences
|
Region: |
Lower Mainland / South Coast
Lower Mainland
|
Tags: |
Aspect Biosystems, biotechnology, 3D human tissue models, Human Tissues on Demand, regenerative medicine
|
|
|
|
Aspect Biosystems is a biotechnology company creating bioprinted tissue therapeutics to transform how we treat disease. Aspect is combining its proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design to create a pipeline of allogeneic tissues that replace or repair damaged organ functions. The company is also partnering with leading researchers and industry innovators worldwide to tackle the biggest challenges in regenerative medicine. Learn more at aspectbiosystems.com. |
|
|
Date |
Type |
Amount |
Investors |
Jan 9, 2020 |
Series A |
$20 Million USD |
Radical Ventures led the round with participation from existing and new investors, including Pangaea Ventures, Pallasite Ventures, and Rhino Ventures. |
Nov 26, 2019 |
Grant |
$0.15 Million CAD |
|
Date |
Type |
Amount |
Investors |
Jan 9, 2020 |
Series A |
$20M USD |
Radical Ventures led the round with participation from existing and new investors, including Pangaea Ventures, Pallasite Ventures, and Rhino Ventures. |
Nov 26, 2019 |
Grant |
$0.15M CAD |
|
|
|
|
Want More Aspect Biosystems News? 1 2
|
Next »
|
|
|
|
|
|
|
Oct 5, 2022
|
Aspect Biosystems Appoints Three New Board Members
|
|
Jun 13, 2022
|
Aspect Biosystems Appoints Five New Scientific Advisors
|
|
Jan 9, 2020
|
Aspect Biosystems Closes $26 Million Series-A Financing to Advance Its Leading Platform for 3D Bioprinting of Human Tissue
|
|
Nov 28, 2019
|
Innovate BC Awards $148,000 Funding for Aspect Biosystems-UBC Collaboration
|
|
Sep 3, 2019
|
Aspect Biosystems Enters Collaboration With McMaster University
|
|
Jun 17, 2019
|
Aspect Biosystems Partners With Merck, GSK, and McGill University to Enable Development of Immuno-Oncology Therapeutics
|
|
Feb 21, 2019
|
Aspect Biosystems and The National Research Council of Canada Work Toward New Ways to Deliver Therapeutics to the Brain
|
|
Jan 31, 2019
|
Aspect Biosystems to Present Preclinical Meniscus Data at Orthopaedic Research Society 2019 Meeting
|
|
Jan 21, 2019
|
Aspect Biosystems Enters Collaboration With Maastricht University to Develop Kidney Tissue
|
|
Nov 21, 2018
|
Aspect Biosystems Receives $2.7 Million Investment From the Government of Canada
|
|
|
1 - 10 of 25 results
|
|
 |
|
|
|
Share This Company Profile |
|
|
|
Disclaimer: Company Profiles in the Tech Directory on T-Net are created, edited and maintained primarily by employees within individual companies, and are subject to continual change without notice and possible errors and/or omissions. Information within the pages of this Tech Directory is of a general nature intended only for informational purposes, and such information should not be relied upon. T-Net does not warrant or guarantee the quality, accuracy or completeness of such information and expressly disclaims liability for any loss, inconvenience or damages (including special, indirect or consequential damages) caused as a result of any errors in, or omissions from, such information. If you see an error, please let us know. Copyright T-Net. All rights reserved.
|
|
News
Events
Tech Careers
Directory
Tech Stocks
T-Net 100
Members
Feedback
About T-Net
Employers
Post Job Listings
Advertise
